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Sir,
We thank Van Gorp et al for their valuable and insightful
comments on our study ‘The impact of lymph node density on
survival of cervical cancer patients’ (Polterauer et al, 2010).
Van Gorp et al raise the question whether or not an intra-
operative finding of bulky nodes may have biased the lymph
node density towards a higher ratio, because the surgeon may
have stopped the operation before completing the systematic
lymphadenectomy. This is a valuable point. To address this
question, we re-analysed our data, looking only at cases with non-
bulky nodes. Still, the lymph node density was a prognosticator
of disease-free survival (P¼0.03). This shows that lymph node
density, that is, the ratio between positive and removed nodes, is
also a valid prognostic marker in women with occult pelvic lymph
node metastases.
Second, another valuable criticism of Van Gorp et al relates to
the influence of the surgeon on the assignment of a given patient to
a prognostic group. In our view, this is not ironic, but may rather
reflect the biology of the tumour. Obviously, the performance of
a surgeon is dependent not only on his/her personal skills, but also
on the surgical case itself. Being able to remove a high amount of
lymph nodes may reflect the biological behaviour, that is,
aggressiveness, of the tumour in the lymph node compartment.
Also, women with a constitutively higher number of lymph nodes
may be more or less suitable to confront tumour cells migrating to
regional lymph nodes on an immunological basis.
Third, the higher median number of lymph nodes removed
may truly reflect a learning curve, as suggested by Van Gorp et al
(Ko ¨hler et al, 2004). This fact, however, should not be influential
on survival, as it affects all cases independently of other prognostic
characteristics.
Furthermore, Van Gorp et al suggested performing a cross-
validation by splitting the data into a training set and a validation
set. This computation was not possible, owing to the limited
number of patients. Nevertheless, we are currently trying to
validate our findings in an independent larger set of data.
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